Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Does the Forecast Indicate for the Non-Steroidal Anti-inflammatory Drugs Market From 2025 to 2029?
The market size for non-steroidal anti-inflammatory drugs has seen substantial growth in recent times. Its value is projected to escalate from $20.68 billion in 2024 to $21.89 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.8%. This marked expansion during the historic timeframe can be directly linked to factors such as an increase in chronic inflammatory diseases, management of post-surgery pain, sports-related injuries, over-the-counter accessibility, an older demographic, and heightened consumer awareness.
The market for non-steroidal anti-inflammatory drugs is anticipated to witness significant expansion in the upcoming years. It will surge to “$28.15 billion in 2029, growing at a compound annual growth rate (CAGR) of 6.5%. The predicted growth during the forecast period could be as a result of the introduction of novel pain management therapies, changes in the regulatory framework, the implementation of telehealth, worldwide wellness trends, an increase in biosimilar competition, changing patient preferences, and the adoption of precision medicine strategies. Key trends in the forecast period encompass the dominance of the over-the-counter (OTC) market, a rising preference for cox-2 inhibitors, competition between generics and the overall market, and the incorporation of digital health technologies.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8023&type=smp
What Elements Are Contributing To Growth In The Non-Steroidal Anti-inflammatory Drugs Market?
The expanding prevalence of chronic pain is anticipated to fuel the expansion of the non-steroidal anti-inflammatory drugs market in the upcoming years. Chronic discomfort is identified as pain that lasts more than six months. Healing injuries and treating chronic pain are primary uses of non-steroidal anti-inflammatory drugs. For instance, a report by the CDC (Centers for Disease Control and Prevention), an US government agency, revealed in April 2022 that chronic pain was commonly caused by arthritis, affecting countless people across the United States. Around one in four adults among 15 million people are suffering from severe joint pain related to arthritis. Hence, the increasing prevalence of chronic pain is propelling the growth of the non-steroidal anti-inflammatory drugs market.
Which Segments Are Detailed In The Global Non-Steroidal Anti-inflammatory Drugs Market Report?
The non-steroidal anti-inflammatory drugs market covered in this report is segmented –
1) By Route Of Administration: Oral, Topical, Other Route Of Administration
2) By Disease Indication: Arthritis, Migraine, Ophthalmic Diseases, Other Disease Indications
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Oral: Tablets, Capsules, Liquids Or Solutions
2) By Topical: Gels, Creams, Patches
3) By Other Route Of Administration: Injectable (Intravenous And Intramuscular), Suppositories
What Are The Leading Trends And Opportunities In The Non-Steroidal Anti-inflammatory Drugs Sector?
One prevailing trend in the non-steroidal anti-inflammatory drugs market is product innovation. This is chiefly carried out by leading corporations in the industry, who are focusing on establishing new technological solutions. In a fitting example from March 2024, Endo International plc, a pharmaceutical firm based out of Ireland, introduced ibuprofen-famotidine 800 mg/26.6 mg tablets to the market. These tablets blend the analgesic and anti-inflammatory benefits of ibuprofen with the gastroprotective advantages of famotidine. This particular formulation has been crafted to both relieve pain and reduce the chance of gastrointestinal side effects, which are potential risks from prolonged ingestion of nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen.
Who Are The Key Contributors To Growth In The Non-Steroidal Anti-inflammatory Drugs Market?
Major companies operating in the non-steroidal anti-inflammatory drugs market are Pfizer Inc., Bayer AG, Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Assertio Therapeutics Inc., Iroko Pharmaceuticals Inc., Reckitt Benckiser Group PLC, Perrigo Company PLC, Hikma Pharmaceuticals Public Limited Company, Glenmark Pharmaceuticals Limited, Septodont, Aspen Pharmacare Holdings Limited, Sagent Pharmaceuticals Inc., Advanced Pharma Inc., Akorn Operating Company LLC, Alembic Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Lupin Limited, Cipla Limited, Zydus Cadila Healthcare Limited, Aurobindo Pharma Limited, Sanofi S.A., GlaxoSmithKline PLC, Horizon Therapeutics PLC, Zyla Life sciences, Novartis AG, Roche Holding AG, AbbVie Inc., Bristol-Myers Squibb Company
Get The Full Report Here:
Which Region Is Projected To Lead The Non-Steroidal Anti-inflammatory Drugs Market By 2025?
North America was the largest region in the non-steroidal anti-inflammatory drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the non-steroidal anti-inflammatory drugs market during the forecast period. The regions covered in the non-steroidal anti-inflammatory drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=8023&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model